The data underlying the results presented in the study are available from the published articles cited in the reference section.

Introduction {#sec001}
============

Antimicrobial resistance (AMR) has been universally recognized as an emerging global problem to public health. Although the prevalence of AMR is sporadic, it is widespread in the Asian region. India, located in the southern part of Asia, marks a high, immeasurable burden of AMR among livestock due to poor documentation, sub-standard regulations with a shortfall in forbidding protocol enforcement \[[@pone.0221771.ref001]\]. This study aims to estimate the pooled prevalence of Extended-spectrum *β*-lactamases (ESBLs) in India by conducting systematic review and meta-analysis with 23 available research articles under epidemiological study design. Beta-Lactam antimicrobial agents are the most favored class of antimicrobials for the treatment of bacterial infections, hence becoming the main cause of resistance to *β*-lactam antibiotics, globally \[[@pone.0221771.ref002]\]. Prevalence of ESBLs producing *Klebsiella* is becoming a major concern in China, Korea, Japan and India \[[@pone.0221771.ref003]\]. ESBLs enzymes are produced by the gram-negative bacteria to incur resistance against the *β*-lactams. *Klebsiella pneumoniae* and *Escherichia coli* are the main gram-negative bacteria producing ESBLs \[[@pone.0221771.ref004]\]. However *Proteus mirabilis*, *Enterobacter* spp., *Salmonella*, *Acinetobacter baumannii*, and *Pseudomonas aeruginosa* also produce ESBLs to acquire resistance \[[@pone.0221771.ref005]\]. The incessant liability of gram-negative strains to a myriad *β*-lactams has begotten rapid and vigorous production and mutation of *β*-lactamases in these bacteria, hence, incurring resistance against the newly developed *β*-lactam antibiotics \[[@pone.0221771.ref002]\]. Treatment for these disease causing multidrug-resistant (MDR) organisms is a therapeutic challenge. The risk factors for developing infection with ESBL-producing organisms include indiscriminate and off-label use of antibiotics \[[@pone.0221771.ref006]\]. At present, animals without any recognized risk factor for multidrug-resistant organisms are found to have ESBL-producing organisms. Hence, diagnosis of ESBL-producing organisms has become vital \[[@pone.0221771.ref007]\]. MDRs are posing a treatment challenge, and a major cause of morbidity and mortality worldwide \[[@pone.0221771.ref001]\]. Unfortunately, India, being a developing country, does not have an adequate surveillance system that could track indiscriminate use or consumption of antibiotics in livestock populations. This meta-analysis will improve our understanding of the distribution of ESBLs in India. A set of similar events for which a study is conducted is called a population, in our study it refers to poultry, bovine and birds. The outcome of our study would indicate the prevalence of ESBLs by zone, year and species in India. It is a quantitative, epidemiological study designed to systematically assess the previous research studies to derive the conclusions of this research \[[@pone.0221771.ref008]\]. This study highlighted the prevalence of ESBL from the time period 2013--2019, with zone-wise and species-wise prevalence of ESBLs in India. A priori protocol was followed for this study with reference to a work done by Bulabula and co-workers \[[@pone.0221771.ref009]\]. To our knowledge, this is the first meta-analysis report from India on animals, which would aid in updating the national treatment guidelines for ESBL infections among animals.

Materials and methods {#sec002}
=====================

Literature search {#sec003}
-----------------

A Systematic search was conducted in "Pub Med", "Google Scholar" and "J-Gate-Plus" databases from Jan 2013 to May 2019 using the search terms "ESBL", "prevalence", "India", "Animals", "Poultry", "Cattle" and "Bovine" in combinations. Bibliographies of eligible studies were also manually searched to identify additional significant articles. A comprehensive search was conducted to ensure none of the research were missed out. The search was restricted to articles published in English.

Study selection criteria {#sec004}
------------------------

All the articles that described the frequency of ESBL producing pathogens among the total isolates from animal samples (clinical/healthy) were considered eligible and included in the study. The qualified articles described the specific laboratory methods used to identify the ESBL producing pathogen along with species of the ESBL producing organism ([Table 1](#pone.0221771.t001){ref-type="table"}). All the enrolled studies were restricted to India. Review articles, case reports and outbreaks were excluded.

10.1371/journal.pone.0221771.t001

###### Characteristics of studies included in the review.
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  Author and year of publication                             State                 Country   Sample type                                                          Number of ESBL positive samples/Total number of samples (% prevalence)   Methodology                                                                                       ESBL producing species
  ---------------------------------------------------------- --------------------- --------- -------------------------------------------------------------------- ------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------- --------------------------------------------------
  **Bandyopadhyay et al. 2018 \[[@pone.0221771.ref025]\]**   West Bengal           India     Bovine milk samples                                                  12/424                                                                   PCR-based detection of major ESBL blaCTX-M-15 gene                                                ESBL producing K. pneumoniae
  **Bhattacharya et al., 2015 \[[@pone.0221771.ref021]\]**   West Bengal           India     Meat and meat products                                               2/80 (2.5%)                                                              Combined Disc Diffusion Test                                                                      ESBL producing *E*. *coli*
  **Bhave et al., 2019 \[[@pone.0221771.ref028]\]**          Maharashtra           India     Cloacal swabs of broilers                                            23/146(15.75%)                                                           PCR-based detection of major ESBL genes (blaTEM, blaSHV, blaCTX-M)                                ESBL producing E. coli
  **Bhoomika et al., 2016 \[[@pone.0221771.ref010]\]**       Chhattisgarh          India     Chicken meat                                                         2/65 (3.08%)                                                             Multiplex-polymerase chain reaction for detection of *bla*~TEM~, *bla*~SHV~,and blaCTX-M genes    ESBL genes in *E*. *coli*
  **Bhoomika et al., 2016 \[[@pone.0221771.ref010]\]**       Chhattisgarh          India     Chevon meat                                                          1/38 (2.63%)                                                             Multiplex-polymerase chain reaction for detection of *bla*~TEM~, *bla*~SHV~, and blaCTX-M genes   ESBL genes in *E*. *coli*
  **Bhoomika et al., 2016 \[[@pone.0221771.ref010]\]**       Chhattisgarh          India     Raw milk                                                             6/73 (8.22%)                                                             Multiplex-polymerase chain reaction for detection of *bla*~TEM~, *bla*~SHV~, and blaCTX-M genes   ESBL genes in *E*. *coli*
  **Brower et al., 2017 \[[@pone.0221771.ref012]\]**         Punjab                India     Cloacal swabs from birds                                             305/1556 (19.60%)                                                        Combination disk method and VITEK 2                                                               ESBL producing *E*. *coli*
  **Chauhan et al., 2013 \[[@pone.0221771.ref013]\]**        Himachal Pradesh      India     Raw milk samples from Doon valley                                    27/100 (27%)                                                             Double disc diffusion method                                                                      ESBL producing *K*. *pneumoniae*
  **Das et al., 2017 \[[@pone.0221771.ref015]\]**            West Bengal           India     Milk samples of subclinical mastitis infected cattle                 24/50 (48%)                                                              PCR-based detection of major ESBL genes (*bla*~TEM~, *bla*~SHV~, *bla*~CTX-M~)                    ESBL producing gram negative isolates
  **Dewangan et al., 2017 \[[@pone.0221771.ref016]\]**       Chhattisgarh          India     Chevon meat                                                          8/126 (6.35%)                                                            Phenotypic detection of ESBL                                                                      ESBL producing *E*. *coli*
  **Dewangan et al., 2017 \[[@pone.0221771.ref016]\]**       Chhattisgarh          India     Raw milk samples                                                     8/104 (7.69%)                                                            Phenotypic detection of ESBL                                                                      ESBL producing *E*. *coli*
  **Kar et al., 2015 \[[@pone.0221771.ref022]\]**            West Bengal           India     Fecal samples from poultry                                           16/170 (9.41%)                                                           Combination disc method and ESBL E-test                                                           ESBL producing *E*. *coli*
  **Kar et al., 2015 \[[@pone.0221771.ref022]\]**            West Bengal           India     Milk samples from cattle                                             2/135 (1.48%)                                                            Combination disc method and ESBL E-test                                                           ESBL producing *E*. *coli*
  **Karuppasamy et al., 2015 \[[@pone.0221771.ref023]\]**    Mizoram               India     Raw milk samples                                                     7/35 (20%)                                                               Kirby-Bauer disc diffusion method                                                                 ESBL producing *E*. *coli* and *K*. *pneumoniae*
  **Koovapra et al., 2016 \[[@pone.0221771.ref040]\]**       West Bengal           India     Bovine milk samples                                                  7/159 (4.40%)                                                            Combination disc diffusion test and ESBL Etest                                                    ESBL producing *K*. *pneumoniae*
  **Koovapra et al., 2016 \[[@pone.0221771.ref040]\]**       Jharkhand             India     Bovine milk samples                                                  10/78 (12.82%)                                                           Combination disc diffusion test and ESBL Etest                                                    ESBL producing *K*. *pneumoniae*
  **Koovapra et al., 2016 \[[@pone.0221771.ref040]\]**       Mizoram               India     Bovine milk samples                                                  6/103 (5.82%)                                                            Combination disc diffusion test and ESBL Etest                                                    ESBL producing *K*. *pneumoniae*
  **Lalzampuia et al., 2013 \[[@pone.0221771.ref016]\]**     Mizoram               India     Fecal samples of pigs                                                7/138 (5.07%)                                                            PCR based detection of ESBLs genes                                                                ESBL genes in *E*. *coli*
  **Lalzampuia et al., 2013 \[[@pone.0221771.ref017]\]**     Mizoram               India     Fecal samples of poultry birds                                       4/102 (3.92%)                                                            PCR based detection of ESBLs genes                                                                ESBL genes in *E*. *coli*
  **Lalzampuia et al., 2014 \[[@pone.0221771.ref018]\]**     Mizoram               India     Fecal samples of poultry birds                                       1/11 (9.09%)                                                             PCR based detection of ESBLs genes                                                                ESBL genes in *K*. *pneumoniae*
  **Mahanti et al., 2017 \[[@pone.0221771.ref014]\]**        West Bengal           India     Cloacal swabs from healthy broiler, indigenous, and kuroiler birds   33/307 (10.75%)                                                          PCR-based detection of major ESBL genes (*bla*~TEM~, *bla*~SHV~, *bla*~CTX-M~)                    ESBL producing *K*. *pneumoniae*
  **Mandakini et al., 2015 \[[@pone.0221771.ref024]\]**      Mizoram               India     Fecal samples of piglets suffering from diarrhea                     43/170 (25.29%)                                                          Double disc synergy test                                                                          ESBL producing *E*. *coli*
  **Nirumapa et al., 2018 \[[@pone.0221771.ref026]\]**       Uttar                 India     Fecal samples of pigs                                                243/741(32.79%)                                                          Double disc diffusion method and Hi-comb MIC test strip                                           ESBL producing *E*. *coli*
  **Raj et al., 2019 \[[@pone.0221771.ref029]\]**            Karnataka             India     Food-animal environment                                              12/43(27.90%)                                                            PCR-based detection of major ESBL blaCTX-M                                                        ESBL producing E. coli
  **Rasheed et al., 2014 \[[@pone.0221771.ref019]\]**        Telangana             India     Unpasteurized milk of buffalo                                        2/30 (6.67%)                                                             Phenotypic Confirmatory Disc Diffusion Test                                                       ESBL producing *E*. *coli*
  **Rasheed et al., 2014 \[[@pone.0221771.ref019]\]**        Telangana             India     Raw chicken                                                          0/30 (0%)                                                                Phenotypic Confirmatory Disc Diffusion Test                                                       ESBL producing *E*. *coli*
  **Rasheed et al., 2014 \[[@pone.0221771.ref019]\]**        Telangana             India     Fresh raw meat of sheep                                              1/30 (3.33%)                                                             Phenotypic Confirmatory Disc Diffusion Test                                                       ESBL producing *E*. *coli*
  **Samanta et al., 2015 \[[@pone.0221771.ref031]\]**        West Bengal           India     Samples from backyard and farmed poultry                             23/360 (6.39%)                                                           PCR-based detection of major ESBL genes (*bla*~TEM~, *bla*~SHV~, *bla*~CTX-M~)                    ESBL producing *E*. *coli*
  **Sharif et al., 2017 \[[@pone.0221771.ref019]\]**         Andhra Pradesh        India     Rectal swab samples from healthy dogs                                2/92 (2.17%)                                                             Combination disc method                                                                           ESBL producing *Pseudomonas* species
  **Sharif et al., 2017 \[[@pone.0221771.ref020]\]**         Andhra Pradesh        India     Rectal swab samples from diarrheic dogs                              5/44 (11.36%)                                                            Combination disc method                                                                           ESBL producing *Pseudomonas* spp.
  **Shrivastav et al., 2016 \[[@pone.0221771.ref041]\]**     Madhya Pradesh        India     Cecal swab samples in healthy broilers                               135/400 (33.75%)                                                         Combined disc diffusion test, DDST, Enz MIC strip                                                 ESBL producing *E*. *coli*
  **Tewari et al., 2018 \[[@pone.0221771.ref027]\]**         Assam                 India     Fecal samples of livestock                                           10/48 (20.83%)                                                           PCR-based detection                                                                               ESBL producing E. coli
  **Tewari et al., 2019 \[[@pone.0221771.ref030]\]**         Meghalaya and Assam   India     Fecal samples of livestock                                           24/32 (75%)                                                              PCR-based detection                                                                               ESBL producing E. coli

Data extraction {#sec005}
---------------

For consistency, data was extracted independently by two people from selected articles. The data extracted from qualified studies included year of publication, first author, location where study was conducted, total sample size, strains detected ESBL positive, and method used for confirmation of ESBL producing pathogen. Any inconsistency in data collection was rectified by re-checking the articles for accuracy.

Quality assessment {#sec006}
------------------

Since it is a prevalence study, use of Newcastle-Ottawa scale is not recommend. However, quality assessment of the study was done on fixed rating scale. This scale includes evaluation of study selection, comparability and outcome, with each section having maximum number of stars as 5, 3 and 2 respectively. Hence, the overall quality assessment has a maximum score of 10 and minimum score for inclusion is 3 stars. [Table 2](#pone.0221771.t002){ref-type="table"} shows the risk of bias assessment for the studies included in quantitative synthesis.

10.1371/journal.pone.0221771.t002

###### Meta-analysis of ESBL prevalence in animals from India.
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  Sl no.             Parameters                   Period       Number of Articles   Number of Studies   Total Events   Pooled Prevalence(With 95% Confidence Interval)   *I*^2^ Value (%)   *τ*^2^ Value   p Value
  ------------------ ---------------------------- ------------ -------------------- ------------------- -------------- ------------------------------------------------- ------------------ -------------- ----------
  **1.**             ESBL prevalence in Animals   2013--2019   17                   27                  6020           10 (7--15)                                        94                 0.8090         p\<0.01
  **Year-Wise**                                                                                                                                                                                            
  **1.**             Year 2013                    2013         2                    2                   238            12 (2--62%)                                       95                 1.7709         p\<0.01
  **2.**             Year 2014                    2014         2                    5                   203            5 (2--9%)                                         0                  0              p = 0.81
  **3.**             Year 2015                    2015         5                    6                   950            8 (3--18%)                                        91                 1.1334         p\<0.01
  **4.**             Year 2016                    2016         3                    7                   916            8 (4--16%)                                        93                 0.6677         p\<0.01
  **5.**             Year 2017                    2017         5                    7                   2279           12 (6--22%)                                       91                 1.0612         p\<0.01
  **6.**             Year 2018                    2018         3                    3                   1213           13(3--55%)                                        95                 1.6353         p\<0.01
  **7.**             Year 2019                    2019         3                    3                   221            33(13--81)                                        97                 0.6148         p\<0.01
  **Zone-Wise**                                                                                                                                                                                            
  **1.**             North Zone                   2013--2017   2                    2                   2397           26 (19--36%)                                      96                 0.0711         p\<0.01
  **2.**             East Zone                    2013--2017   10                   14                  1978           11 (6--18%)                                       95                 0.9394         p\<0.01
  **3.**             West Zone                    \-           0                    0                   \-             \-                                                \-                 \-             \-
  **4.**             South Zone                   2014--2017   2                    5                   226            6 (3--11%)                                        36                 0.2815         p = 0.20
  **5.**             Central Zone                 2016--2017   3                    6                   806            8 (4--18%)                                        92                 0.6864         p\<0.01
  **Species-Wise**                                                                                                                                                                                         
  **1.**             *Escherichia coli*           2013--2017   11                   17                  4526           9 (6--15%)                                        92                 0.8028         p\<0.01
  **2.**             *K*. *pneumoniae*            2013--2017   4                    6                   758            10 (6--19%)                                       85                 0.3852         p\<0.01
  **3.**             *Pseudomonas* spp.           2017         1                    2                   136            5 (1--24%)                                        76                 1.0345         p = 0.04

Statistical analysis {#sec007}
--------------------

Meta-analysis for the prevalence of ESBL producing pathogens among animal samples were conducted using the R Open source scripting software (version 3.4.3, R Foundation for Statistical Computing, Vienna, Austria. <https://www.R-project.org/>) \[[@pone.0221771.ref010]\]. The inbuilt packages used for analysis were Metafor and Meta R packages.

In the analysis, both random effect and fixed effect model were used to calculate the pooled prevalence of ESBL and *I*^2^ statistic (to measure inconsistency). The *τ*^2^ statistic was also calculated to measure the heterogeneity. Further, sub-group analysis was performed to reduce heterogeneity. In the present study, the data was stratified based on: year-wise (2013--2019) zone-wise (North, East, West, South and Central zones) and species-wise (*E*. *coli*, *Pseudomonas* spp., and *K*. *pneumoniae*).

Results {#sec008}
=======

Distribution and characteristics of articles describing ESBLs in India {#sec009}
----------------------------------------------------------------------

The electronic database searches returned 32 potential articles based on the keyword search. Review articles studying the ESBL prevalence in humans were excluded. A total of 23 articles were selected suitable for the study. The flowchart of systematic article selection is shown in [Fig 1](#pone.0221771.g001){ref-type="fig"}. All the articles included in the study described the prevalence of ESBL producing pathogens isolated from animals/animal samples from India. The maximum number of studies on this subject were found in the eastern zone followed by central, south and north zone. No studies were found from western zone of India. In total, 20 studies were on ESBLs produced by *Escherichia coli*, 6 on ESBLs produced by *K*. *pneumoniae* and 2 on ESBLs produced from *Pseudomonas* spp. The animal samples studied in the articles mainly included meat samples, milk samples, rectal swabs, cecal swabs and cloacal swabs from poultry birds, sheep, pig and cattle.

![The flow diagram of study selection process.](pone.0221771.g001){#pone.0221771.g001}

Pooled prevalence of ESBLs in animal samples {#sec010}
--------------------------------------------

The meta-analysis revealed the overall pooled prevalence of ESBL in animals to be 9% (95% CI: 6--13%; *τ*^2^ = 0.6654; *P* \< 0.01\*\*). The prevalence estimates of ESBL producing pathogens in India is depicted in the forest plot in [Fig 2](#pone.0221771.g002){ref-type="fig"}, which also displays the author, year, samples, events and total samples \[[@pone.0221771.ref011]--[@pone.0221771.ref020]\]. In order to reduce the heterogeneity, the studies on ESBL producing isolates were categorized by Year, Zone and Species-wise ([Table 3](#pone.0221771.t003){ref-type="table"}). The pooled prevalence of ESBL producing pathogens in animals were 12, 5, 8, 8, 12, 13 and 33% for the years 2013, 2014, 2015, 2016, 2017, 2018 and 2019 respectively, as depicted in the forest plot \[[@pone.0221771.ref020]--[@pone.0221771.ref030]\] in ([Fig 3A--3G](#pone.0221771.g003){ref-type="fig"}). The zone-wise prevalence percentage of ESBLs were 26, 11, 6 and 8% for the north, east, south and central zones are shown in ([Fig 4A--4D](#pone.0221771.g004){ref-type="fig"}). The species-wise prevalence of ESBLs were found to be 9, 10 and 5% for *E*.*coli*, *K*. *pneumoniae* and *Pseudomonas spp*. respectively. Figs [5](#pone.0221771.g005){ref-type="fig"}--[7](#pone.0221771.g007){ref-type="fig"} explains the forest plot of species-wise Meta-analysis.

![Forest plot of ESBL prevalence in India from 2013--2019.](pone.0221771.g002){#pone.0221771.g002}

![Forest plots of ESBL prevalence in (a) 2013; (b) 2014; (c) 2015; (d) 2016; (e) 2017; (f) 2018; and (g) 2019.](pone.0221771.g003){#pone.0221771.g003}

![Forest plots of ESBL prevalence in (a) north-zone; (b) east-zone; (c) south-zone; and (d) central-zone.](pone.0221771.g004){#pone.0221771.g004}

![Forest plot of *E. coli* producing ESBL prevalence.](pone.0221771.g005){#pone.0221771.g005}

![Forest plot of *K. pneumonia* producing ESBL prevalence.](pone.0221771.g006){#pone.0221771.g006}

![Forest plot of *Pseudomonas spp*. producing ESBL prevalence.](pone.0221771.g007){#pone.0221771.g007}

10.1371/journal.pone.0221771.t003

###### Risk of bias assessment for studies included in the quantitative synthesis.
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  Author and year of publication                             Selection                                                                                                                                                 Comparability                                                                                                                                    Outcome                                   Overall Quality Assessment score                                    
  ---------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------- ------------------------------------------------------------------- ---
  **Bandyopadhyay et al. 2018 \[[@pone.0221771.ref025]\]**   [\*](#t003fn003){ref-type="table-fn"}Truly representative bovine milk samples                                                                             [\*\*](#t003fn004){ref-type="table-fn"}ESBL production confirmed by PCR                                                                          Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   3
  **Bhattacharya et al., 2015 \[[@pone.0221771.ref020]\]**   [\*](#t003fn003){ref-type="table-fn"}Truly representative Meat and meat products with antibiotic resistance                                               [\*](#t003fn003){ref-type="table-fn"}ESBL production diagnosed by Combined Disc Diffusion Test                                                   Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   3
  **Bhave et al., 2019 \[[@pone.0221771.ref028]\]**          [\*](#t003fn003){ref-type="table-fn"}Truly representative Cloacal swabs from broiler                                                                      [\*](#t003fn003){ref-type="table-fn"}ESBL production diagnosed by Combined Disc Diffusion Test                                                   Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   4
  **Bhoomika et al., 2016 \[[@pone.0221771.ref010]\]**       [\*](#t003fn003){ref-type="table-fn"}Truly representative of chicken meat samples with antibiotic resistance                                              [\*\*](#t003fn004){ref-type="table-fn"}Chicken meat samples diagnosed with clinical isolates producing ESBL confirmed by Multiplex PCR           Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   4
  **Bhoomika et al., 2016 \[[@pone.0221771.ref010]\]**       [\*](#t003fn003){ref-type="table-fn"}Truly representative of chevon meat samples with antibiotic resistance                                               [\*\*](#t003fn004){ref-type="table-fn"}Chevon meat samples diagnosed with clinical isolates producing ESBL confirmed by Multiplex PCR            Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   4
  **Bhoomika et al., 2016 \[[@pone.0221771.ref010]\]**       [\*](#t003fn003){ref-type="table-fn"}Truly representative of raw milk samples with antibiotic resistance                                                  [\*\*](#t003fn004){ref-type="table-fn"}Raw milk samples diagnosed with clinical isolates producing ESBL confirmed by Multiplex PCR               Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   4
  **Brower et al., 2017 \[[@pone.0221771.ref011]\]**         [\*](#t003fn003){ref-type="table-fn"}Truly representative Cloacal swabs from birds with antibiotic resistance                                             [\*](#t003fn003){ref-type="table-fn"}ESBL production diagnosed by Combination disk method and VITEK 2                                            Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   3
  **Chauhan et al., 2013 \[[@pone.0221771.ref012]\]**        [\*](#t003fn003){ref-type="table-fn"}Truly representative Raw milk samples from Doon valley with antibiotic resistance                                    [\*](#t003fn003){ref-type="table-fn"}ESBL production diagnosed by Double disc diffusion method                                                   Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   3
  **Das et al., 2017 \[[@pone.0221771.ref014]\]**            [\*](#t003fn003){ref-type="table-fn"}Truly representative of sub-clinical mastic milk samples with antibiotic resistance                                  [\*\*](#t003fn004){ref-type="table-fn"}Sub-clinical mastic milk samples diagnosed with clinical isolates producing ESBL confirmed by PCR         Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   4
  **Dewangan et al., 2017 \[[@pone.0221771.ref015]\]**       [\*](#t003fn003){ref-type="table-fn"}Truly representative Chevon meat with antibiotic resistance                                                          [\*](#t003fn003){ref-type="table-fn"}ESBL production diagnosed by Phenotypic detection of ESBL                                                   Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   3
  **Dewangan et al., 2017 \[[@pone.0221771.ref015]\]**       [\*](#t003fn003){ref-type="table-fn"}Truly representative Raw milk samples with antibiotic resistance                                                     [\*](#t003fn003){ref-type="table-fn"}ESBL production diagnosed by Phenotypic detection of ESBL                                                   Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   3
  **Kar et al., 2015 \[[@pone.0221771.ref021]\]**            [\*](#t003fn003){ref-type="table-fn"}Truly representative Fecal samples from poultry with antibiotic resistance                                           [\*](#t003fn003){ref-type="table-fn"}ESBL production diagnosed by Combination disc method and ESBL E-test                                        Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   3
  **Kar et al., 2015 \[[@pone.0221771.ref021]\]**            [\*](#t003fn003){ref-type="table-fn"}Truly representative Milk samples from cattle with antibiotic resistance                                             [\*](#t003fn003){ref-type="table-fn"}ESBL production diagnosed by Combination disc method and ESBL E-test                                        Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   3
  **Karuppasamy et al., 2015 \[[@pone.0221771.ref022]\]**    [\*](#t003fn003){ref-type="table-fn"}Truly representative Raw milk samples with antibiotic resistance                                                     [\*](#t003fn003){ref-type="table-fn"}ESBL production diagnosed by Kirby Bauer disc diffusion test                                                Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   3
  **Koovapra et al.,2016 \[[@pone.0221771.ref033]\]**        [\*](#t003fn003){ref-type="table-fn"}Truly representative Bovine milk samples with antibiotic resistance                                                  ESBL production diagnosed by Combination disc diffusion test and ESBL Etest                                                                      Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   3
  **Lalzampuia et al., 2013 \[[@pone.0221771.ref016]\]**     [\*](#t003fn003){ref-type="table-fn"}Truly representative Fecal samples of pigs with antibiotic resistance                                                [\*\*](#t003fn004){ref-type="table-fn"}Pigs with history of diarrhea diagnosed with clinical isolates producing ESBL confirmed by PCR            Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   4
  **Lalzampuia et al., 2014 \[[@pone.0221771.ref017]\]**     [\*](#t003fn003){ref-type="table-fn"}Truly representative Fecal samples of poultry birds with antibiotic resistance                                       [\*\*](#t003fn004){ref-type="table-fn"}Poultry birds with history of diarrhea diagnosed with clinical isolates producing ESBL confirmed by PCR   Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   4
  **Lalzampuia et al., 2014 \[[@pone.0221771.ref017]\]**     [\*](#t003fn003){ref-type="table-fn"}Truly representative Fecal samples of poultry birds with antibiotic resistance                                       [\*\*](#t003fn004){ref-type="table-fn"}Poultry birds with history of diarrhea diagnosed with clinical isolates producing ESBL confirmed by PCR   Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   4
  **Mahanti et al., 2017 \[[@pone.0221771.ref013]\]**        [\*](#t003fn003){ref-type="table-fn"}Truly representative Cloacal swabs from healthy broiler, indigenous, and kuroiler birds with antibiotic resistance   [\*\*](#t003fn004){ref-type="table-fn"}ESBL production confirmed by PCR                                                                          Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   4
  **Mandakini et al., 2015 \[[@pone.0221771.ref023]\]**      [\*](#t003fn003){ref-type="table-fn"}Truly representative Fecal samples of piglets suffering from diarrhea with antibiotic resistance                     [\*](#t003fn003){ref-type="table-fn"}ESBL production diagnosed by Double disc synergy test                                                       Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   3
  **Nirumapa et al., 2018 \[[@pone.0221771.ref026]\]**       [\*](#t003fn003){ref-type="table-fn"}Truly representative Fecal samples of pigs                                                                           [\*\*](#t003fn004){ref-type="table-fn"} ESBL production diagnosed by Double disc diffusion method and Hi-comb MIC test strip                     Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   3
  **Raj et al., 2019 \[[@pone.0221771.ref029]\]**            [\*](#t003fn003){ref-type="table-fn"} Truly representative Food-animal environment                                                                        [\*\*](#t003fn004){ref-type="table-fn"}ESBL production diagnosed by PCR                                                                          Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   3
  **Rasheed et al., 2014 \[[@pone.0221771.ref018]\]**        [\*](#t003fn003){ref-type="table-fn"}Truly representative Unpasteurized milk of buffalo with antibiotic resistance                                        [\*](#t003fn003){ref-type="table-fn"}ESBL production diagnosed by Phenotypic Confirmatory Disc Diffusion Test                                    Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   3
  **Rasheed et al., 2014 \[[@pone.0221771.ref018]\]**        [\*](#t003fn003){ref-type="table-fn"}Truly representative Raw chicken with antibiotic resistance                                                          [\*](#t003fn003){ref-type="table-fn"}ESBL production diagnosed by Phenotypic Confirmatory Disc Diffusion Test                                    Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   3
  **Rasheed et al., 2014 \[[@pone.0221771.ref018]\]**        [\*](#t003fn003){ref-type="table-fn"}Truly representative Fresh raw meat of sheep with antibiotic resistance                                              [\*](#t003fn003){ref-type="table-fn"}ESBL production diagnosed by Phenotypic Confirmatory Disc Diffusion Test                                    Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   3
  **Samanta et al., 2015 \[[@pone.0221771.ref024]\]**        [\*](#t003fn003){ref-type="table-fn"}Truly representative Samples from backyard and farmed poultry with antibiotic resistance                             [\*\*](#t003fn004){ref-type="table-fn"}ESBL production confirmed by PCR                                                                          Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   4
  **Sharif et al., 2017 \[[@pone.0221771.ref019]\]**         [\*](#t003fn003){ref-type="table-fn"}Truly representative Rectal swab samples from healthy dogs with antibiotic resistance                                [\*](#t003fn003){ref-type="table-fn"}ESBL production diagnosed by Combined Disc Diffusion Test                                                   Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   3
  **Sharif et al., 2017 \[[@pone.0221771.ref019]\]**         [\*](#t003fn003){ref-type="table-fn"}Truly representative Rectal swab samples from diarrheic dogs with antibiotic resistance                              [\*](#t003fn003){ref-type="table-fn"}ESBL production diagnosed by Combined Disc Diffusion Test                                                   Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   3
  **Shrivastav et al., 2016 \[[@pone.0221771.ref035]\]**     [\*](#t003fn003){ref-type="table-fn"}Truly representative Cecal swab samples in healthy broilers with antibiotic resistance                               [\*](#t003fn003){ref-type="table-fn"}ESBL production diagnosed by CDDT, DDST and Enz MIC strip in Healthy broilers                               Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   3
  **Tewari et al., 2018 \[[@pone.0221771.ref027]\]**         [\*](#t003fn003){ref-type="table-fn"}Truly representative Fecal samples of livestock                                                                      [\*\*](#t003fn004){ref-type="table-fn"}ESBL production confirmed by PCR                                                                          Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   3
  **Tewari et al., 2019 \[[@pone.0221771.ref030]\]**         [\*](#t003fn003){ref-type="table-fn"}Truly representative Fecal samples of livestock                                                                      [\*\*](#t003fn004){ref-type="table-fn"}ESBL production confirmed by PCR                                                                          Study did not control for other factors   [\*](#t003fn003){ref-type="table-fn"}Independent blind assessment   3

PCR, Polymerase chain Reaction; CDDT, Combined disc diffusion test; DDST, Double disc synergy test, Enz MIC strip, Enz Minimum Inhibitory Concentration strip; E test, Epsilometer test.

(\*)Stars represent the number of points awarded for the category;

\* = 1,

\*\* = 2.

Discussion {#sec011}
==========

Our study revealed that, the ESBL producing clinical isolates in India may not be very high, nonetheless it is significant. These drug-resistant pathogens are a serious concern worldwide as they are associated with increase in morbidity and mortality rate due to infections they cause \[[@pone.0221771.ref031]\]. Extended-Spectrum Beta-Lactamases are produced by species of bacteria in order to inactivate antibiotics, causing antibiotic resistance. Beta-lactamase seems to be the prime cause in multidrug resistant (MDR) *E*. *coli* strains. Early detection of *E*. *coli* that produce beta lactamase is necessary in order to prevent MDR *E*. *coli* from spreading \[[@pone.0221771.ref032]\]. Activity of ESBLs caused by different beta-lactamases resulted in resistant genes within the farm \[[@pone.0221771.ref033]\]. The strains that were isolated showed that a small portion of the resistant genes were present in one farm \[[@pone.0221771.ref004]\]~.~ The steep rise in income and the growing population has driven an increase in demand for animal products in India. India is one of the top consumers of antibiotics worldwide, it accounts for about 3% of global consumption which is estimated to double by 2030. This could be due to the non-therapeutic use of antibiotics in cases of prophylaxis and growth promotion \[[@pone.0221771.ref034]\]. Currently, the usage of antibiotics is high in poultry, swine and cattle production as compared to that being used by the human population \[[@pone.0221771.ref035]--[@pone.0221771.ref036]\].

To address the concern of antimicrobial resistant bacteria, it is crucial to raise awareness of the problem by collecting data on antibiotic resistance from various countries and regions. The paucity of studies available from India affirms attention for future research. To our knowledge, this is the first meta-analysis regarding the magnitude of the ESBL problem in Indian animal population. From the 23 articles chosen in the study, the overall pooled prevalence of ESBL producing isolates from the animal samples was found to be 10%. In Asia, high rates of ESBL producing *Enterobacteriaceae* are seen with variation in the prevalence and the genotype of the ESBL producing isolates over the large geographical area \[[@pone.0221771.ref030]\].

The prevalence of ESBL producing isolates were 12, 5, 8, 8, 12, 13 and 33% for the years 2013, 2014, 2015, 2016, 2017, 2018 and 2019 respectively, indicating an increase in the percent drug resistance since 2014 to 2019. The pooled prevalence of ESBL producing isolates was determined zone-wise and North zone showed a higher prevalence rate in comparison to other zones. Nonetheless, no studies on prevalence of ESBL producing isolates for animal samples from the Western zone of India are reported. Prevalence of species-wise classification was found to be 9, 10 and 5% for *E*. *coli*, *K*. *pneumoniae* and *Pseudomonas* spp. respectively, signifying that the ESBL producing *K*. *pneumoniae* is the most predominant ESBL producing isolate in India.

A study conducted in the intensive care units (ICUs) of an Indian hospital concluded that there is a need for constant surveillance to detect resistant bacterial strains, strict guidelines on antibiotic therapy, and effective infection control measures in order to reduce the spread of antibiotic resistant bacteria. The same study also revealed that there is a high number of ESBL producing *E*. *coli* in the ICUs of that hospital \[[@pone.0221771.ref031]\]. A study with pediatric and neonatal patients estimated the number of poor outcomes and indicated the association of blood stream infections (BSIs) with Extended-Spectrum Beta-Lactamase- producing *Enterobacteriaceae* (ESBL-PE). The results showed a high prevalence of BSIs due to ESBL-PE and increase in neonatal mortality \[[@pone.0221771.ref037]--[@pone.0221771.ref039]\]. A study from Germany demonstrated that direct transfer of ESBL-producing E. *coli* could occur between livestock and the farm workers who were in close contact with farm animals. The study also suggests an existence of epidemiological links between livestock and farm workers. A high prevalence of ESBL-producing *E*. *coli* in pig and cattle farms emphasizes the fact that livestock animals are a constant source for these potential human pathogens \[[@pone.0221771.ref033], [@pone.0221771.ref040]--[@pone.0221771.ref041]\].

Our research findings does have some minor limitations, which includes the lack of sufficient information on the prevalence of ESBL producers from different animal species. Upon advanced literature survey, we could find only a few articles that addressed the prevalence of ESBLs in animals.

Conclusion {#sec012}
==========

India being a developing country, has the highest burden of bacterial infections. Hence, to combat this downfall, antibiotics are used widely and indiscriminately. The overuse, lack of awareness and non-therapeutic use of antibiotics is driving an increase in the antibiotic resistance among animals. This meta-analysis, indicated that the pooled prevalence of ESBLs for animals in India is not high, however, the overall prevalence remains significant at 10%. Additionally, only little information is currently available that addresses the prevalence of ESBLs in animals in India. The paucity of data on the clinical outcomes, magnitude and prevalence of the resistant ESBLs, calls for active surveillance which can help understand the epidemiology of ESBL burden in India. Furthermore, emphasis on awareness programs, personal and environmental hygiene should be implemented to stop and manage the spread of ESBLs to the animals and environment. Further studies are needed to better understand the complexity of the AMR problem in animal and human population.
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